Details

Autor(en) / Beteiligte

• Gilard, Martine
• Eltchaninoff, Hélène
• Iung, Bernard
• Donzeau-Gouge, Patrick
• Chevreul, Karine
• Fajadet, Jean
• Leprince, Pascal
• Leguerrier, Alain
• Lievre, Michel
• Prat, Alain
• Teiger, Emmanuel
• Lefevre, Thierry
• Himbert, Dominique
• Tchetche, Didier
• Carrié, Didier
• Albat, Bernard
• Cribier, Alain
• Rioufol, Gilles
• Sudre, Arnaud
• Blanchard, Didier
• Collet, Frederic
• Santos, Pierre Dos
• Meneveau, Nicolas
• Tirouvanziam, Ashok
• Caussin, Christophe
• Guyon, Philippe
• Boschat, Jacques
• Le Breton, Herve
• Collart, Frederic
• Houel, Remi
• Delpine, Stephane
• Souteyrand, Geraud
• Favereau, Xavier
• Ohlmann, Patrick
• Doisy, Vincent
• Grollier, Gilles
• Gommeaux, Antoine
• Claudel, Jean-Philippe
• Bourlon, Francois
• Bertrand, Bernard
• Van Belle, Eric
• Laskar, Marc

Titel

Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients

Ist Teil von

• The New England journal of medicine, 2012-05, Vol.366 (18), p.1705-1715

Ort / Verlag

Waltham, MA: Massachusetts Medical Society

Erscheinungsjahr

2012

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Data from a French registry of nearly 3200 transcatheter aortic-valve implantation (TAVI) procedures complement data from randomized clinical trials. This emerging technique shows promise in the treatment of high-risk patients with aortic stenosis. Aortic stenosis is now the most frequently diagnosed valvular disease. 1 , 2 Surgical aortic-valve replacement is the definitive therapy for patients with severe symptomatic aortic stenosis. 2 , 3 Operative mortality is low among selected elderly patients but increases with the number and severity of coexisting illnesses. 4 – 6 A survey of hospitalized patients revealed the underreferral to surgery of those with severe symptomatic aortic stenosis. 7 Transcatheter aortic-valve implantation (TAVI) was developed as an alternative to surgical aortic-valve replacement in this high-risk patient population. Ten years after the first implantation by Cribier and colleagues, 8 more than 50,000 patients have been treated by TAVI worldwide. . . .